Ruicheng Venture Capital

Founding Partner Chen Weizhong leads investment decisions. Public records name Chen as the firm's principal, and the governance structure is consistent with the founding-partner-led model common among first-generation, renminbi-denominated Chinese venture firms. No investment committee members beyond Chen are publicly disclosed.

Ruicheng sources proprietary deal flow through long-term relationships with technology transfer offices and faculty labs at institutions including Tsinghua University, Shanghai Jiao Tong University, and the Chinese Academy of Sciences. The firm targets research-stage spinouts that have not yet been formally marketed to the broader venture community. This research-lab channel is the firm's primary differentiator for early access to deep-science founders.

Ruicheng is structured as a third-party venture capital manager, not a single family office. It raises capital from external limited partners, which include state-backed guidance funds and domestic institutional investors, and operates a standard GP-LP fund structure with a management fee and carried interest.

The firm targets seed and Series A stages, with initial checks in the single-digit millions of dollars. Ruicheng reserves capital to follow portfolio companies into later expansion rounds, and maintains a concentrated portfolio with fewer than two dozen active positions at any time. This early-entry, high-conviction posture is suited to technology risk from lab-stage innovation.

Ruicheng does not publicly maintain an explicit avoid list. Based on the firm's disclosed focus areas — applied AI, enterprise software, industrial automation, and healthcare services — the investment strategy effectively excludes consumer internet, content platforms, and asset-heavy industries outside its research-lab sourcing funnel. There is no record of Ruicheng investing in consumer-facing mobile apps or real estate development.